NY2267 is a disruptor of Myc-Max interaction , with an IC 50 of 36.5 μM. NY2267 inhibits Myc- and Jun-induced transcriptional activation.
In Vitro
NY2267 strongly inhibits oncogenic transformation induced by Myc. MCE has not independently confirmed the accuracy of these methods. They are for reference only.